Autologous bone marrow clot as an alternative to autograft for bone defect healing

Abstract

As similar treatment outcomes were achieved by the two strategies, the preferred treatment would be one that is associated with a lower risk of complications. Hence, these results demonstrate that coagulated BMA can be considered as an alternative autogenous therapy for long bone healing.<b>Cite this article</b>: Z. X. H. Lim, B. Rai, T. C. Tan, A. K. Ramruttun, J. H. Hui, V. Nurcombe, S. H. Teoh, S. M. Cool. Autologous bone marrow clot as an alternative to autograft for bone defect healing. <i>Bone Joint Res</i> 2019;8:107-117. DOI: 10.1302/2046-3758.83.BJR-2018-0096.R1.